Everest Medicines Limited announced that Dr. Kerry Blanchard has resigned as a member of the Board of Directors, effective immediately. He will remain as an advisor to Everest for the six months following his resignation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.05 HKD | +1.15% | -4.34% | +5.50% |
14/05 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
14/05 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.50% | 893M | |
-2.29% | 89.38B | |
-3.95% | 37.92B | |
-13.07% | 32.04B | |
+63.05% | 26.03B | |
-22.14% | 14.14B | |
-7.96% | 12.88B | |
-9.33% | 11.77B | |
-46.33% | 10.85B | |
+5.77% | 8.92B |
- Stock Market
- Equities
- 1952 Stock
- News Everest Medicines Limited
- Everest Medicines Limited Announces Resignation of Kerry Blanchard as A Member of the Board of Directors